Department of Pharmacology and Toxicology, Ahram Canadian University, 6th of October City, Giza 12566, Egypt.
Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, AB T6G 1Z2, Canada.
Nutrients. 2018 Apr 6;10(4):454. doi: 10.3390/nu10040454.
Glioblastoma multiforme (GBM) is a highly infiltrative brain cancer with a dismal prognosis. High levels of brain fatty acid binding protein (B-FABP) are associated with increased migration/infiltration in GBM cells, with a high ratio of arachidonic acid (AA) to docosahexaenoic acid (DHA) driving B-FABP-mediated migration. Since several protein kinase Cs (PKCs) are overexpressed in GBM and linked to migration, we explored a possible relationship between B-FABP and levels/activity of different PKCs, as a function of AA and DHA supplementation. We report that ectopic expression of B-FABP in U87 cells alters the levels of several PKCs, particularly PKC. Upon analysis of RNA levels in a panel of GBM cell lines and patient-derived GBM neurospheres, we observed a trend towards moderate positive correlation ( = 0.624, = 0.054) between B-FABP and RNA levels. Analysis of PKC activity in U87 GBM cells revealed decreased typical PKC activity (23.4%) in B-FABP-expressing cells compared with nonexpressing cells, with no difference in novel and atypical PKC activities. AA and DHA modulated both conventional and atypical PKC activities in a B-FABP-dependent manner, but had no effect on novel PKC activity. These results suggest that conventional and atypical PKCs are potential downstream effectors of B-FABP/fatty acid-mediated alterations in GBM growth properties.
多形性胶质母细胞瘤(GBM)是一种具有侵袭性的脑癌,预后不良。脑脂肪酸结合蛋白(B-FABP)水平升高与 GBM 细胞迁移/浸润增加有关,花生四烯酸(AA)与二十二碳六烯酸(DHA)的高比值驱动 B-FABP 介导的迁移。由于几种蛋白激酶 C(PKCs)在 GBM 中过度表达,并与迁移有关,我们研究了 B-FABP 与不同 PKCs 的水平/活性之间可能存在的关系,作为 AA 和 DHA 补充的函数。我们报告说,B-FABP 在 U87 细胞中的异位表达改变了几种 PKCs 的水平,特别是 PKC。在对一组 GBM 细胞系和患者来源的 GBM 神经球中的 RNA 水平进行分析后,我们观察到 B-FABP 和 RNA 水平之间存在中度正相关( = 0.624, = 0.054)的趋势。在 U87 GBM 细胞中分析 PKC 活性时,与不表达细胞相比,表达 B-FABP 的细胞中典型 PKC 活性降低了 23.4%,而新型和非典型 PKC 活性没有差异。AA 和 DHA 以 B-FABP 依赖的方式调节经典和非经典 PKC 活性,但对新型 PKC 活性没有影响。这些结果表明,经典和非经典 PKCs 是 B-FABP/脂肪酸介导的 GBM 生长特性改变的潜在下游效应物。